Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-623 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate |
2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-WO2016013400-A1 |
titleOfInvention |
Biomarker for lung cancer diagnosis |
abstract |
The present invention relates to a method for testing lung cancer and an antibody specifically recognizing gelsolin and / or complement component C9, comprising detecting gelsolin and / or complement component C9 in an immune complex recovered from a sample derived from a subject. A kit for examining lung cancer, which comprises an antibody that specifically recognizes L, is provided. |
priorityDate |
2014-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |